20 clinical trials found.
-
PERSPECTIVES OF PROVIDERS ON HIGH QUALITY CARE OF LGBTQIA+ PATIENTS WITH INFLAMMATORY BOWEL DISEASE
This is a qualitative interview study to better understand provider attitudes and perspectives for providing high quality care in sexual and gender minorities (SGM) patients ...Phase N/A
TRIAL ROLE: Principal Investigator
-
Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)
IBD Plexus is a research and information exchange platform whose goal is to accelerate research and transform the care of patients with IBD. IBD Plexus ...Phase N/A TRIAL ROLE: Sub Investigator
-
Corevitas Inflammatory Bowel Disease (IBD) Registry
The primary objective for this registry is to prospectively study the natural history of IBD, the prevalence and incidence of comorbidities, and targeted adverse events ...Phase N/A TRIAL ROLE: Sub Investigator
-
Standardized Microbiota Transplant Therapy in Crohn s Disease.
This study aims to examine the relationship between the intestinal microbiota and Crohn’s disease (CD) phenotype, and to evaluate whether modifying the microbiota can ...Phase N/A TRIAL ROLE: Sub Investigator
-
ICONIC-UC: Phase 3 randomized double-blind placebo-controlled study in adults and open-label in adolescents to evaluate efficacy and safety of icotrokinra for induction and maintenance in moderate to severe ulcerative colitis.
The purpose of this study is to learn more about a study medicine called icotrokinra and to find out if it is safe and helps ...Phase
TRIAL ROLE: Sub Investigator
-
An Open-Label Phase 4 Single-Arm Multicenter Study to Evaluate the Induction of Response and Remission of Vedolizumab Dual Targeted Therapy with Tofacitinib in Adult Patients with Moderately to Severely Active Ulcerative Colitis
This is a phase 4, interventional, open-label, single-arm, multicenter study in adult participants with moderately to severely active ulcerative colitis (UC) who have experienced inadequate ...Phase
TRIAL ROLE: Sub Investigator
-
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
This study will enroll patients who are starting treatment with Zymfentra (infliximab-dyyb) for irritable bowel disease (IBD). This study will collect information about responses to ...Phase N/A TRIAL ROLE: Sub Investigator
-
EFC18325 A multicenter multinational randomized double-blind placebo-controlled Phase 3 induction study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcerative Colitis
The purpose of this research study is to study an experimental drug SAR447189, also called duvakitug, for the treatment of moderate to severe Ulcerative Colitis ...Phase
TRIAL ROLE: Sub Investigator
-
EFC18326 - A multicenter multinational randomized double-blind placebo-controlled Phase 3 induction study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn s Disease
The purpose of this research study is to study an experimental drug SAR447189, also called duvakitug, for the treatment of moderate to severe Crohn’s ...Phase
TRIAL ROLE: Sub Investigator
-
A PHASE III MULTICENTER DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF INDUCTION THERAPY WITH RO7790121 IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS - GA45330
Inflammatory bowel disease (IBD) is a complex and debilitating disease that significantly affects people’s lives. The most common forms of IBD are Crohn’s ...Phase
TRIAL ROLE: Sub Investigator
